Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable?
José Luis Gálvez-RomeroJ Deveaux-HomsF A Real-RamírezO Palmeros-RojasSigifredo Pedraza-SánchezPublished in: Journal of internal medicine (2021)
Keyphrases